Silo Pharma, Inc. (SILO) stock
SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.89+0.18 (+10.53%)
Close on Nov 18, 2026Market cap $3.00MP/E –Yield –
Silo Pharma operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Silo Pharma's operating income for the twelve months ending Jun 30, 2026 was -$4.46M. For fiscal 2025 it was -$4.28M. The highest annual figure on record is -$490.87K in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.28M | – |
| FY2024 | Dec 31, 2024 | -$4.71M | – |
| FY2023 | Dec 31, 2023 | -$3.86M | – |
| FY2022 | Dec 31, 2022 | -$3.63M | – |
| FY2021 | Dec 31, 2021 | -$2.74M | – |
| FY2020 | Dec 31, 2020 | -$2.20M | – |
| FY2019 | Dec 31, 2019 | -$930.40K | – |
| FY2018 | Dec 31, 2018 | -$594.24K | – |
| FY2017 | Dec 31, 2017 | -$490.87K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$928.95K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.59M | – |
| Q4 FY2025 | Dec 31, 2025 | -$786.52K | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.15M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.25M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.09M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.81M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.01M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.16M | – |
| Q1 FY2023 | Jun 30, 2023 | -$1.92M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.66M | – |
| Q3 FY2022 | Sep 30, 2022 | -$949.15K | – |
| Q2 FY2022 | Jun 30, 2022 | -$494.29K | – |
| Q1 FY2022 | Mar 31, 2022 | -$527.26K | – |
| Q4 FY2021 | Dec 31, 2021 | -$942.42K | – |
| Q3 FY2021 | Sep 30, 2021 | -$463.94K | – |
| Q2 FY2021 | Jun 30, 2021 | -$436.85K | – |
| Q1 FY2021 | Mar 31, 2021 | -$901.14K | – |
| Q4 FY2020 | Dec 31, 2020 | -$591.58K | – |
| Q3 FY2020 | Sep 30, 2020 | -$558.89K | – |
| Q2 FY2020 | Jun 30, 2020 | -$996.69K | – |
| Q1 FY2020 | Mar 31, 2020 | -$159.36K | – |
| Q4 FY2019 | Dec 31, 2019 | -$323.46K | – |
| Q3 FY2019 | Sep 30, 2019 | -$242.51K | – |
| Q2 FY2019 | Jun 30, 2019 | -$189.87K | – |
| Q1 FY2019 | Mar 31, 2019 | -$174.57K | – |
| Q4 FY2018 | Dec 31, 2018 | -$302.10K | – |
| Q3 FY2018 | Sep 30, 2018 | -$81.18K | – |
| Q2 FY2018 | Jun 30, 2018 | -$76.11K | – |
| Q1 FY2018 | Mar 31, 2018 | -$134.86K | – |
See a number that looks wrong?